The Promise and the Hype of 'Personalised Medicine'
The Promise and the Hype of 'Personalised Medicine' - PubMed
Personalised medicine is widely considered as the way of the future for medicine. However, progress in cancer, with a few outstanding exceptions, ...
The Promise and the Hype of 'Personalised Medicine' - PMC
Personalised medicine is widely considered as the way of the future for medicine. However, progress in cancer, with a few outstanding ...
Personalised Medicine: The Promise, the Hype and the Pitfalls
This editorial discusses and interrelates the articles of the issue under four headings: the promise and the hype of personalised medicine.
The Promise and the Hype of 'Personalised Medicine'
Personalised medicine that includes a sober appreciation of what genomics can achieve, together with continued focus on the individual as a person not just ...
The Promise and the Hype of 'Personalised Medicine' - ResearchGate
PDF | Personalised medicine is widely considered as the way of the future for medicine. However, progress in cancer, with a few outstanding exceptions,.
Personalised Medicine: The Promise, the Hype and the Pitfalls.
This editorial discusses and interrelates the articles of the issue under four headings: the promise and the hype of personalised medicine; the human person and ...
Personalized medicine: The promise, the hype and the pitfalls
The healthcare institution? The funding body? This new study explores the conundrum of personal health data ownership. It considers the ...
Steve Sturdy: The promise and the hype of 'personalised medicine'
A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine.
The Promise and the hype of 'personalised medicine' - ORA
In both benign and malignant disease, diseases caused by single genetic alterations are more amenable to precision medicine approaches. However, ...
Personalised Medicine: The Promise, the Hype and the Pitfalls
This paper is part of the Special Issue on “Personalised Medicine: The Promise, the. Hype and the Pitfalls”, guest edited by Therese Feiler, Kezia Gaitskell, ...
Personalised Medicine, the Promise the Hype and the Pitfalls ...
9th September 2016. Excerpt from the conference programme booklet, providing the context to the presentations: “Participation and data sharing presents a ...
Personalised medicine: the promise, the hype and the pitfalls - The ...
University of Oxford, Healthcare Values Partnership. Supported by the Wellcome Trust.Speakers include: Tim Maughan (Professor of Clinical Oncology, University ...
Personalised Medicine: The Promise, the Hype and the Pitfalls
Request PDF | Personalised Medicine: The Promise, the Hype and the Pitfalls | In engaging critically with personalised medicine and mapping pitfalls which ...
Hope or Hype – Professor Don Chalmers – 28 July 2013
In the pharmaceutical area, personalised medicine aims, based on an individual's genetic profile, to develop new drugs, to better match drugs to ...
Precision Medicine Has Been Overhyped | Scientific American
Medicine. During the past two decades or so, personalized medicine has gotten a lot of hype. The promise is this: researchers can use a ...
U philosopher's new book challenges the hype surrounding ... - @theU
A new book by philosophy professor James Tabery, “Tyranny of the Gene,” critiques personalized medicine.
Personalised Medicine: The promise, the hype and the pitfalls
Personalised Medicine: The promise, the hype and the pitfalls. TORCH | The Oxford Research Centre in the Humanities.
Personalised Medicine: The Promise, the Hype and the Pitfalls
Personalised Medicine: The Promise, the Hype and the Pitfalls. Therese Feiler 1. ,. Kezia Gaitskell 1. ,. Tim Maughan 1. ,. Joshua Hordern 1.
Personalized medicine: hope or hype? | European Heart Journal
As genome sequencing declines in cost, the availability of specific genomic information will no longer be limiting. Rather, our ability to parse ...
From hype to reality: data science enabling personalized medicine
The key idea is to base medical decisions on individual patient characteristics, including molecular and behavioral biomarkers, rather than on ...